No Data
603716 Thalys Medical Technology Group Corporation.
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Thalys Medical Technology Group Corporation. Company
The company was founded in February 2004 and is headquartered in Wuhan City, Hubei Province, and has its own 27,000 square meter industrial park. The company successfully entered the capital market in October 2016 and was the first medical intensive operation service provider listed on the Shanghai Main Board in the central region. The company defined a development strategy based on the medical smart supply chain service business (IVD intensive, regional testing center, SPD) while collaborating with upstream advanced technology and the out-of-hospital ToC patient diagnosis and treatment service market (chronic disease management PBM, Internet home care). The main products are coagulation reagents, etc. Corporate honors: outstanding entrepreneurs; top 100 service enterprises in Wuhan; outstanding listed enterprises; top 20 manufacturing tax paying enterprises in 2013, etc.
News
Seri Healthcare (603716.SH): “Seri Convertible Bonds” is expected to trigger downward revision conditions in the conversion price
Glonghui, September 22, 丨 Seri Healthcare (603716.SH) announced that from September 11, 2023 to September 22, 2023, the closing price of the company's stock for 10 out of 30 consecutive trading days was lower than 85% of the current conversion price (14.43 yuan/share), which is expected to trigger the “Seri Bonds” conversion price correction conditions.
Shengang Securities: Driven by both policy and market, the SPD industry ushered in a new round of development opportunities
Currently, the market is in a period of explosion
Seri Healthcare (603716.SH): Net profit of 1.53 million yuan in the first half of the year fell 8.9% year on year
Glonghui, August 29丨Celi Healthcare (603716.SH) announced its semi-annual report. Operating income was 1.01 billion yuan, down 12.09% year on year, net profit was 1.53 million yuan, down 8.9% year on year, net profit was 1.53 million yuan, down 8.9% year on year, after deducting non-net loss of 6.06 million yuan, converted to losses year on year, and basic earnings per share were 0.0075 yuan.